PetMed Express d/b/a 1-800-PetMeds Announces Its Third Fiscal Quarter Financial Results and Its Quarterly Dividend of $0.28 Per Share
Quarterly Sales Increased 10%
Diluted EPS increased from $0.34 to $0.38 per share
Quarterly Average Order Size increased to $88
DELRAY BEACH, Fla., Jan. 19, 2021 (GLOBE NEWSWIRE) -- PetMed Express, Inc. (NASDAQ: PETS) today announced its financial results for the quarter ended December 31, 2020. Net sales for the quarter ended December 31, 2020 were $65.9 million, compared to $59.9 million for the quarter ended December 31, 2019, an increase of 10.0%. Net sales for the nine months ended December 31, 2020 were $237.5 million, compared to $209.8 million for the nine months ended December 31, 2019, an increase of 13.2%. Net income was $7.6 million, or $0.38 diluted per share, for the quarter ended December 31, 2020, compared to net income of $6.8 million, or $0.34 diluted per share, for the quarter ended December 31, 2019, an 11.3% increase to net income. Net income was $23.8 million, or $1.18 diluted per share, for the nine months ended December 31, 2020, compared to net income of $18.8 million, or $0.94 diluted per share, for the nine months ended December 31, 2019, a 26.0% increase to net income. Reorder sales increased 11.9%, to $60.2 million for the quarter ended December 31, 2020, compared to $53.8 million for the same quarter in the prior year. Reorder sales increased 13.6%, to $208.4 million for the nine months ended December 31, 2020, compared to $183.4 million for the same period in the prior year.
Menderes Akdag, CEO and President, commented: “We were pleased with the Company’s performance during the quarter and throughout 2020, where we have seen both double digit top and bottom line growth. Strong reorder sales and increasing gross and operating margins during the quarter contributed to our success. Our reorder growth for the three and nine months ended on December 31, 2020 was likely energized by the increased use of loyalty credits by our customers through our Loyalty Program, which was launched in September 2019, and by our Easy Refill Program. Our average order size increased from $85 to $88 for the quarters ended December 31, 2019 and 2020, respectively. In the beginning of 2021 we unveiled a new logo to commemorate the Company’s 25th anniversary. The inspiration for this new logo and brand identity came mostly from consumer feedback. We embraced the opportunity to refresh our logo and brand to best represent both pet health and wellness on our new website platform. In the next fiscal year, we will be exploring alternative ways of acquiring new customers and adding value-added services, and we will continue investing in our e-commerce platform and mobile app to optimize our customers’ digital experience.”
The Board of Directors declared a quarterly dividend of $0.28 per share on the Company’s common stock. The dividend will be payable on February 12, 2021, to shareholders of record at the close of business on February 1, 2021. The Company intends to continue to pay regular quarterly dividends; however, the declaration and payment of future dividends is discretionary and will be subject to a determination by the Board of Directors each quarter following its review of the Company’s financial performance.
This morning at 8:30 A.M. Eastern Time, the Company will host a conference call to review the quarter’s financial results. To access the call, which is open to the public, please dial (888) 455-1758 (toll free) or (203) 827-7025. Callers will be required to supply PETMEDS as the passcode. For those unable to participate in the live event, the call will be available for replay from 10:00 A.M. on January 19, 2021 until February 2, 2021 at 11:59 P.M. Eastern Time. To access the replay, call (888) 676-2680 (toll free) or (402) 220-6446, and enter passcode 5500.
Founded in 1996, PetMed Express is America’s Most Trusted Pet Pharmacy, delivering prescription and non-prescription pet medications and other health products for dogs, cats, and horses at competitive prices direct to the consumer through its 1-800-PetMeds toll free number and on the Internet through its website at .
This press release may contain “forward-looking” statements, as defined in the Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission, that involve a number of risks and uncertainties, including the Company’s ability to meet the objectives included in its business plan. Important factors that could cause results to differ materially from those indicated by such “forward-looking” statements are set forth in Management’s Discussion and Analysis of Financial Condition and Results of Operations in the PetMed Express Annual Report on Form 10-K for the year ended March 31, 2020. The Company’s future results may also be impacted by other risk factors listed from time to time in its SEC filings, including, but not limited to, the Company's Form 10-Q and its Annual Report on Form 10-K. For investment relations contact PetMed Express, Inc., Bruce S. Rosenbloom, CFO, 561-526-4444.
| PETMED EXPRESS, INC. AND SUBSIDIARIES | ||||
| CONDENSED CONSOLIDATED BALANCE SHEETS | ||||
| (In thousands, except for per share data) | ||||
| December 31, | March 31, | |||
| 2020 | 2020 | |||
| ASSETS | (Unaudited) | |||
| Current assets: | ||||
| Cash and cash equivalents | $ | 106,501 | $ | 103,762 |
| Accounts receivable, less allowance for doubtful | ||||
| accounts of $28 and $59, respectively | 1,831 | 3,843 | ||
| Inventories - finished goods | 28,165 | 17,884 | ||
| Prepaid expenses and other current assets | 4,512 | 3,529 | ||
| Total current assets | 141,009 | 129,018 | ||
| Noncurrent assets: | ||||
| Property and equipment, net | 25,502 | 25,445 | ||
| Intangible assets | 860 | 860 | ||
| Total noncurrent assets | 26,362 | 26,305 | ||
| Total assets | $ | 167,371 | $ | 155,323 |
| LIABILITIES AND SHAREHOLDERS' EQUITY | ||||
| Current liabilities: | ||||
| Accounts payable | $ | 21,869 | $ | 19,658 |
| Accrued expenses and other current liabilities | 4,429 | 4,214 | ||
| Income taxes payable | 623 | 471 | ||
| Total current liabilities | 26,921 | 24,343 | ||
| Deferred tax liabilities | 1,323 | 970 | ||
| Total liabilities | 28,244 | 25,313 | ||
| Commitments and contingencies | ||||
| Shareholders' equity: | ||||
| Preferred stock, $.001 par value, 5,000 shares authorized; | ||||
| 3 convertible shares issued and outstanding with a | ||||
| liquidation preference of $4 per share | 9 | 9 | ||
| Common stock, $.001 par value, 40,000 shares authorized; | ||||
| 20,271 and 20,166 shares issued and outstanding, respectively | 20 | 20 | ||
| Additional paid-in capital | 6,098 | 3,804 | ||
| Retained earnings | 133,000 | 126,177 | ||
| Total shareholders' equity | 139,127 | 130,010 | ||
| Total liabilities and shareholders' equity | $ | 167,371 | $ | 155,323 |
| PETMED EXPRESS, INC. AND SUBSIDIARIES | ||||||||
| CONDENSED CONSOLIDATED STATEMENTS OF INCOME | ||||||||
| (In thousands, except for per share amounts) (Unaudited) | ||||||||
| Three Months Ended | Nine Months Ended | |||||||
| December 31, | December 31, | |||||||
| 2020 | 2019 | 2020 | 2019 | |||||
| Sales | $ | 65,896 | $ | 59,915 | $ | 237,536 | $ | 209,839 |
| Cost of sales | 46,273 | 42,218 | 168,110 | 150,279 | ||||
| Gross profit | 19,623 | 17,697 | 69,426 | 59,560 | ||||
| Operating expenses: | ||||||||
| General and administrative | 6,487 | 6,040 | 21,050 | 18,851 | ||||
| Advertising | 3,221 | 3,163 | 17,385 | 16,543 | ||||
| Depreciation | 622 | 562 | 1,791 | 1,702 | ||||
| Total operating expenses | 10,330 | 9,765 | 40,226 | 37,096 | ||||
| Income from operations | 9,293 | 7,932 | 29,200 | 22,464 | ||||
| Other income: | ||||||||
| Interest income, net | 73 | 421 | 229 | 1,447 | ||||
| Other, net | 345 | 301 | 938 | 862 | ||||
| Total other income | 418 | 722 | 1,167 | 2,309 | ||||
| Income before provision for income taxes | 9,711 | 8,654 | 30,367 | 24,773 | ||||
| Provision for income taxes | 2,100 | 1,814 | 6,576 | 5,925 | ||||
| Net income | $ | 7,611 | $ | 6,840 | $ | 23,791 | $ | 18,848 |
| Net income per common share: | ||||||||
| Basic | $ | 0.38 | $ | 0.34 | $ | 1.19 | $ | 0.94 |
| Diluted | $ | 0.38 | $ | 0.34 | $ | 1.18 | $ | 0.94 |
| Weighted average number of common shares outstanding: | ||||||||
| Basic | 20,094 | 19,984 | 20,047 | 20,060 | ||||
| Diluted | 20,104 | 19,994 | 20,100 | 20,071 | ||||
| Cash dividends declared per common share | $ | 0.28 | $ | 0.27 | $ | 0.84 | $ | 0.81 |
| PETMED EXPRESS, INC. AND SUBSIDIARIES | ||||||
| CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS | ||||||
| (In thousands) (Unaudited) | ||||||
| Nine Months Ended | ||||||
| December 31, | ||||||
| 2020 | 2019 | |||||
| Cash flows from operating activities: | ||||||
| Net income | $ | 23,791 | $ | 18,848 | ||
| Adjustments to reconcile net income to net cash | ||||||
| provided by operating activities: | ||||||
| Depreciation | 1,791 | 1,702 | ||||
| Share based compensation | 2,294 | 2,081 | ||||
| Deferred income taxes | 353 | (12 | ) | |||
| Bad debt expense | 84 | 102 | ||||
| (Increase) decrease in operating assets | ||||||
| and increase (decrease) in liabilities: | ||||||
| Accounts receivable | 1,928 | 388 | ||||
| Inventories - finished goods | (10,281 | ) | (2,795 | ) | ||
| Prepaid income taxes | - | 582 | ||||
| Prepaid expenses and other current assets | (983 | ) | (1,424 | ) | ||
| Accounts payable | 2,211 | 360 | ||||
| Accrued expenses and other current liabilities | 286 | 851 | ||||
| Income taxes payable | 152 | 895 | ||||
| Net cash provided by operating activities | 21,626 | 21,578 | ||||
| Cash flows from investing activities: | ||||||
| Purchases of property and equipment | (1,848 | ) | (1,827 | ) | ||
| Net cash used in investing activities | (1,848 | ) | (1,827 | ) | ||
| Cash flows from financing activities: | ||||||
| Repurchase and retirement of common stock | - | (11,496 | ) | |||
| Dividends paid | (17,039 | ) | (16,410 | ) | ||
| Net cash used in financing activities | (17,039 | ) | (27,906 | ) | ||
| Net increase (decrease) in cash and cash equivalents | 2,739 | (8,155 | ) | |||
| Cash and cash equivalents, at beginning of period | 103,762 | 100,529 | ||||
| Cash and cash equivalents, at end of period | $ | 106,501 | $ | 92,374 | ||
| Supplemental disclosure of cash flow information: | ||||||
| Cash paid for income taxes | $ | 6,356 | $ | 4,460 | ||
| Property and equipment in current assets | $ | - | $ | 1,344 | ||
| Dividends payable in accrued expenses | $ | 174 | $ | 196 | ||
